Changeflow GovPing Pharma & Drug Safety Gilead Sciences Patent EP4464703A2 on Ikaros Zi...
Routine Notice Added Final

Gilead Sciences Patent EP4464703A2 on Ikaros Zinc Finger Degraders

Favicon for changeflow.com ChangeBridge: EPO Bulletin - Therapeutics (A61P)
Published March 18th, 2026
Detected March 25th, 2026
Email

Summary

The European Patent Office has published patent application EP4464703A2 by Gilead Sciences, Inc. concerning Ikaros Zinc Finger Family Degraders and their uses. The patent application details novel compounds and methods for potential therapeutic applications.

What changed

This document is a publication of a European patent application (EP4464703A2) filed by Gilead Sciences, Inc. The patent covers "IKAROS ZINC FINGER FAMILY DEGRADERS AND USES THEREOF," detailing specific chemical compounds and their potential applications, likely in the field of therapeutics. The publication date is March 18, 2026.

As this is a patent publication, it does not impose direct compliance obligations on regulated entities. However, it is relevant for pharmaceutical companies and drug manufacturers engaged in research and development, particularly in oncology or related fields, as it pertains to intellectual property and novel drug candidates. Legal and R&D departments should note this publication for competitive intelligence and potential licensing or infringement considerations.

Source document (simplified)

← EPO Patent Bulletin

IKAROS ZINC FINGER FAMILY DEGRADERS AND USES THEREOF

Publication EP4464703A2 Kind: A2 Mar 18, 2026

Applicants

Gilead Sciences, Inc.

Inventors

BALAN, Gayatri, BLOMGREN, Peter A., CHEN, Chen, CODELLI, Julian A., DU, Zhimin, KIM, Musong, SADDIER AXE, Dorothée, SCHWARZWALDER, Gregg M., THOMAS-TRAN, Rhiannon, TUDESCO, Michael T., VENKATARAMANI, Chandrasekar, WATKINS, William J., WEIST, Brian M., YEUNG, Suet, C., YU, Helen

IPC Classifications

C07D 401/04 20060101AFI20260206BHEP C07D 405/12 20060101ALI20260206BHEP A61P 35/00 20060101ALI20260206BHEP C07D 401/14 20060101ALI20260206BHEP C07D 405/14 20060101ALI20260206BHEP C07D 417/14 20060101ALI20260206BHEP A61K 31/4035 20060101ALI20260206BHEP C07D 409/14 20060101ALI20260206BHEP C07D 493/08 20060101ALI20260206BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, ME, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR

View original document →

Named provisions

IKAROS ZINC FINGER FAMILY DEGRADERS AND USES THEREOF

Classification

Agency
EPO
Published
March 18th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
EP4464703A2

Who this affects

Applies to
Drug manufacturers Pharmaceutical companies
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Drug Development Intellectual Property Management
Geographic scope
European Union EU

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Legal
Compliance frameworks
FDA 21 CFR Part 11 GxP
Topics
Intellectual Property Drug Development

Get Pharma & Drug Safety alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when ChangeBridge: EPO Bulletin - Therapeutics (A61P) publishes new changes.

Optional. Personalizes your daily digest.

Free. Unsubscribe anytime.